High Efficacy of Sofosbuvir/Velpatasvir/GS-9857 With or Without Ribavirin for 12 Weeks in Direct-Acting Antiviral-Experienced Patients With Genotype 1 HCV Infection

Press/Media: Press / Media

PeriodJun 13 2017

Media coverage

1

Media coverage

  • TitleHigh Efficacy of Sofosbuvir/Velpatasvir/GS-9857 With or Without Ribavirin for 12 Weeks in Direct-Acting Antiviral-Experienced Patients With Genotype 1 HCV Infection
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date6/13/17
    PersonsFred Poordad, Eric J Lawitz